Neostigmine Other names: Prostigmin Vagostigmin

Chemical formula: C₁₂H₁₉N₂O₂⁺  Molecular mass: 223.292 g/mol  PubChem compound: 4456

Active ingredient description

Neostigmine inhibits cholinesterase activity and prolongs and intensifies the muscarinic and nicotinic effects of acetylcholine. The anticholinesterase actions of neostigmine are reversible. It is used mainly for its action on skeletal muscle and less frequently to increase the activity of smooth muscle.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
N07AA01 Neostigmine N Nervous system → N07 Other nervous system drugs → N07A Parasympathomimetics → N07AA Anticholinesterases
Discover more medicines within N07AA01
S01EB06 Neostigmine S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EB Parasympathomimetics
Discover more medicines within S01EB06

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
NEOSTIGMINE BROMIDE Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NEOSTIGMINE Sterile injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 114-80-7
CAS Substance: 51-60-5
DrugBank Drug: DB01400
KEGG Drug: D08261
PubChem Compound: 4456
RxNorm Ingredient: 7315
SNOMED-CT Concept: 373346001
Neostigmine (substance)
UNII Identifier: 3982TWQ96G
NEOSTIGMINE

Medicines

Neostigmine is an active ingredient of these brands:

United States (US)

Austria (AT)

  • NEOSTIG as NEOSTIGMINE METHYLSULFATE

  • (combination) COMBISTIG as NEOSTIGMINE METHYLSULFATE

Brazil (BR)

Croatia (HR)

  • (combination) NOVISTIG as NEOSTIGMINE METHYLSULFATE

Estonia (EE)

Finland (FI)

France (FR)

Ireland (IE)

  • (combination) NOVISTIG as NEOSTIGMINE METHYLSULFATE

Japan (JP)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

  • PROSTIGMIN as NEOSTIGMINE METHYLSULFATE

  • (combination) NOVISTIG as NEOSTIGMINE METHYLSULFATE

Poland (PL)

Romania (RO)

Singapore (SG)

  • SETISIN as NEOSTIGMINE METHYLSULFATE

South Africa (ZA)

  • (combination) CHOLSTYQ as NEOSTIGMINE METHYLSULFATE

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.